This dosage information may not include all the information needed to use Glipizide safely and effectively. See additional information for Glipizide.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
Usual Adult Dose for:
Usual Geriatric Dose for:
Additional dosage information:
Usual Adult Dose for Diabetes Mellitus Type II
Initial dose: 5 mg (immediate or sustained-release) orally once a day, 30 minutes before breakfast.
Maintenance dose: 2.5 to 30 mg (immediate-release) orally in 1 or 2 divided doses or 5 to 20 mg (sustained-release) orally in 1 or 2 divided doses.
Usual Geriatric Dose for Diabetes Mellitus Type II
Initial dose: 2.5 to 5 mg orally once a day. Doses may be increased in 1 or 2 week intervals in 2.5 to 5 mg/day increments.
Renal Dose Adjustments
Initial dose for patients with renal insufficiency (CrCl 25 to 49 mL/min) is 2.5 mg orally once a day. Glipizide is not recommended for use in severely renally impaired patients (CrCl less than 25 mL/min).
Liver Dose Adjustments
Initial dose: 2.5 mg orally once a day. Doses may be increased in 1 to 2 week intervals in 2.5 to 5 mg/day increments.
Dosage adjustments should be made in no more than 2.5 to 5 mg increments every 5 to 7 days. Doses greater than 15 mg/day should generally be divided. Patients stabilized on immediate-release glipizide may be switched to sustained-release at the nearest total daily dose.
Patients switched from longer acting agents, such as chlorpropamide, should be carefully monitored for hypoglycemia in the first 2 weeks of therapy.
Safety and effectiveness have not been established in pediatric patients (less than 18 years of age).
Data not available
Immediate release: The maximum recommended once-daily dose is 15 mg; maximum recommended total daily dose is 40 mg.
Sustained release: The maximum daily dose is 20 mg.